Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease


Smoking is a leading cause of preventable death, causing about 5 million premature deaths worldwide each year1,2. Evidence for genetic influence on smoking behaviour and nicotine dependence (ND)3,4,5,6,7,8 has prompted a search for susceptibility genes. Furthermore, assessing the impact of sequence variants on smoking-related diseases is important to public health9,10. Smoking is the major risk factor for lung cancer (LC)11,12,13,14 and is one of the main risk factors for peripheral arterial disease (PAD)15,16,17. Here we identify a common variant in the nicotinic acetylcholine receptor gene cluster on chromosome 15q24 with an effect on smoking quantity, ND and the risk of two smoking-related diseases in populations of European descent. The variant has an effect on the number of cigarettes smoked per day in our sample of smokers. The same variant was associated with ND in a previous genome-wide association study that used low-quantity smokers as controls18,19, and with a similar approach we observe a highly significant association with ND. A comparison of cases of LC and PAD with population controls each showed that the variant confers risk of LC and PAD. The findings provide a case study of a gene–environment interaction20, highlighting the role of nicotine addiction in the pathology of other serious diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others


  1. Anonymous Annual smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 1997–2001. MMWR Morb. Mortal. Wkly. Rep. 54, 625–628 (2005)

    Google Scholar 

  2. World Health Organization. Economics of tobacco control. 〈

  3. Carmelli, D., Swan, G. E., Robinette, D. & Fabsitz, R. Genetic influence on smoking—a study of male twins. N. Engl. J. Med. 327, 829–833 (1992)

    Article  CAS  Google Scholar 

  4. Li, M. D., Cheng, R., Ma, J. Z. & Swan, G. E. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98, 23–31 (2003)

    Article  Google Scholar 

  5. Kendler, K. S. et al. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol. Med. 29, 299–308 (1999)

    Article  CAS  Google Scholar 

  6. Heath, A. C. & Martin, N. G. Genetic models for the natural history of smoking: evidence for a genetic influence on smoking persistence. Addict. Behav. 18, 19–34 (1993)

    Article  CAS  Google Scholar 

  7. Madden, P. A. et al. The genetics of smoking persistence in men and women: a multicultural study. Behav. Genet. 29, 423–431 (1999)

    Article  CAS  Google Scholar 

  8. Vink, J. M., Willemsen, G., Beem, A. L. & Boomsma, D. I. The Fagerstrom Test for Nicotine Dependence in a Dutch sample of daily smokers and ex-smokers. Addict. Behav. 30, 575–579 (2005)

    Article  Google Scholar 

  9. Carlsten, C. & Burke, W. Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations. J. Am. Med. Assoc. 296, 2480–2482 (2006)

    Article  CAS  Google Scholar 

  10. Bierut, L. J. et al. Genetic research and smoking behavior. J. Am. Med. Assoc. 297, 809 (2007)

    Article  CAS  Google Scholar 

  11. Doll, R. & Hill, A. B. A study of the aetiology of carcinoma of the lung. BMJ 2, 1271–1286 (1952)

    Article  CAS  Google Scholar 

  12. Doll, R. & Peto, R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J. Epidemiol. Community Health 32, 303–313 (1978)

    Article  CAS  Google Scholar 

  13. Wynder, E. L. & Graham, E. A. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J. Am. Med. Assoc. 143, 329–336 (1950)

    Article  CAS  Google Scholar 

  14. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74–108 (2005)

    Article  Google Scholar 

  15. Hirsch, A. T. et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113, e463–e654 (2006)

    Article  Google Scholar 

  16. Powell, J. T. et al. Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study. Atherosclerosis 129, 41–48 (1997)

    Article  CAS  Google Scholar 

  17. Price, J. F. et al. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur. Heart J. 20, 344–353 (1999)

    Article  CAS  Google Scholar 

  18. Saccone, S. F. et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet. 16, 36–49 (2007)

    Article  CAS  Google Scholar 

  19. Bierut, L. J. et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 16, 24–35 (2007)

    Article  CAS  Google Scholar 

  20. Plomin, R., DeFries, J. C. & Loehlin, J. C. Genotype–environment interaction and correlation in the analysis of human behavior. Psychol. Bull. 84, 309–322 (1977)

    Article  CAS  Google Scholar 

  21. Berrettini, W. et al. α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol. Psychiatry (in the press)

  22. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. & Fagerstrom, K. O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 86, 1119–1127 (1991)

    Article  CAS  Google Scholar 

  23. Rose, J. E. Nicotine addiction and treatment. Annu. Rev. Med. 47, 493–507 (1996)

    Article  CAS  Google Scholar 

  24. Russell, M. A. The nicotine addiction trap: a 40-year sentence for four cigarettes. Br. J. Addict. 85, 293–300 (1990)

    Article  CAS  Google Scholar 

  25. Stolerman, I. P. & Jarvis, M. J. The scientific case that nicotine is addictive. Psychopharmacology (Berl.) 117, 2–10 (1995)

    Article  CAS  Google Scholar 

  26. Haiman, C. A. et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N. Engl. J. Med. 354, 333–342 (2006)

    Article  CAS  Google Scholar 

  27. Stellman, S. D. et al. Lung cancer risk in white and black Americans. Ann. Epidemiol. 13, 294–302 (2003)

    Article  Google Scholar 

  28. Peto, R. et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. Br. Med. J. 321, 323–329 (2000)

    Article  CAS  Google Scholar 

  29. Devlin, B., Bacanu, S. A. & Roeder, K. Genomic control to the extreme. Nature Genet. 36, 1129–1130 (2004)

    Article  CAS  Google Scholar 

  30. Grant, S. F. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genet. 38, 320–323 (2006)

    Article  ADS  CAS  Google Scholar 

  31. Gulcher, J. R., Kristjansson, K., Gudbjartsson, H. & Stefansson, K. Protection of privacy by third-party encryption in genetic research in Iceland. Eur. J. Hum. Genet. 8, 739–742 (2000)

    Article  CAS  Google Scholar 

  32. Thorgeirsson, T. E. et al. Anxiety with panic disorder linked to chromosome 9q in Iceland. Am. J. Hum. Genet. 72, 1221–1230 (2003)

    Article  CAS  Google Scholar 

  33. Mueller, T. et al. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study. J. Vasc. Surg. 41, 808–815 (2005)

    Article  Google Scholar 

  34. Rutherford, R. B. et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J. Vasc. Surg. 26, 517–538 (1997)

    Article  CAS  Google Scholar 

  35. Dormandy, J. A. & Rutherford, R. B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J. Vasc. Surg. 31, S1–S296 (2000)

    Article  CAS  Google Scholar 

  36. Barani, J., Nilsson, J. A., Mattiasson, I., Lindblad, B. & Gottsater, A. Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. J. Vasc. Surg. 42, 75–80 (2005)

    Article  Google Scholar 

  37. Anonymous Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J. Vasc. Surg. 4, 80–94 (1986)

    Article  Google Scholar 

  38. Flex, A. et al. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur. J. Vasc. Endovasc. Surg. 24, 264–268 (2002)

    Article  CAS  Google Scholar 

  39. Barrett, J. C. & Cardon, L. R. Evaluating coverage of genome-wide association studies. Nature Genet. 38, 659–662 (2006)

    Article  CAS  Google Scholar 

Download references


We thank the participants in the genetic studies whose contributions made this work possible, the staff at Noatun (deCODE’s recruitment centre), and personnel at deCODE’s core facilities. This work was supported in part by funds from the National Institute of Drug Abuse and the European Commission.

Author Contributions T.E.T., F.G., P.S., and T.R. contributed equally to this work. T.E.T., F.G., P.S, T.R., A.W., D.F.G., A.K. and K.S. wrote the first draft of the paper. Ha.S., H.J.I., T.G. and S.J. recruited and diagnosed the Icelandic lung cancer patients. S.E.M. recruited and diagnosed the Icelandic peripheral arterial disease patients. T.B., H.K., J.G.S., I.H, V.R., H.O., T.T. and S.J. recruited and diagnosed nicotine addiction subjects. K.K.H.A., F.d.V., P.F.A.M. and L.A.K. recruited and diagnosed the subjects from The Netherlands. D.I., M.J.V., L.A., B.S., L.M. and J.I.M. recruited and diagnosed the Spanish subjects. G.T.J. and A.M.v.R. recruited and diagnosed the subjects from New Zealand. T.M., B.P. and M.H. recruited and diagnosed subjects from Austria. A.G. and B.L. recruited and diagnosed subjects from Sweden. A.F. and R.P. recruited and diagnosed subjects from Italy. A.W., A.I., S.N.S., J.T.B., S.T., J.G., M.J., J.S., O.O. and S.N.S. performed genotyping and experimental work. L.J.G., G.B. and K.K. incorporated phenotypic data into a database and analysed it. T.E.T., F.G., P.S., T.R., A.W., K.P.M., A.M., G.T., D.F.G. and A.K. analysed the data. T.E.T., F.G., P.S., T.R., K.P.M., Hr.S., T.J., J.I.M., L.K., H.O., T.T., J.R.G., S.J., D.G., U.T., A.K. and K.S. planned, supervised and coordinated the work. All authors contributed to the final version of the paper.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Thorgeir E. Thorgeirsson or Kari Stefansson.

Ethics declarations

Competing interests

Some of the authors employed by deCODE genetics own stock or stock options in the company

Supplementary information

Supplementary Information

This file contains Supplementary Methods, Supplementary Results, Supplementary Figure 1, Supplementary Tables 1-6, and additional references. (PDF 292 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thorgeirsson, T., Geller, F., Sulem, P. et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638–642 (2008).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing